About Us

Jennifer Gottlieb Appointed to Muscular Dystrophy Association’s Board of Directors

San Francisco, June 22, 2020 – Jennifer Gottlieb, Global President of W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, has been named to the Board of Directors for the Muscular Dystrophy Association (MDA).

“I am honored to join MDA in its mission to improve the lives of people and families affected by neuromuscular diseases, especially given how vulnerable the population is during the current COVID-19 crisis,” said Gottlieb. “I look forward to bringing my deep healthcare experience to MDA to expand fundraising efforts and digital-enablement in support of innovations in science and care.”

MDA is committed to transforming the lives of people affected by muscular dystrophy, ALS and related neuromuscular diseases. Through innovations in science and care, MDA is creating more hope and answers for families living with muscular dystrophy and related diseases that take away physical strength and mobility. Research supported by MDA is directly linked to approved, life-changing therapies across multiple neuromuscular diseases. Additionally, MDA supports the largest network of multidisciplinary clinics providing best-in-class care at more than 150 of the nation’s top medical institutions. Each year, thousands of children and young adults with neuromuscular diseases learn vital life skills and gain independence at MDA’s summer camp and through recreational programs, at no cost to families.

“At this challenging time, we must remember that many diseases, especially neuromuscular diseases such as muscular dystrophy, spinal muscular atrophy, and ALS, urgently need innovations in research and care. MDA is an essential charity, and our patients are more vulnerable than ever. We are on the front-line delivering care to over 50,000 people and bringing critical education and resources to over 250,000,” said MDA President and CEO Lynn O’Connor Vos. “Jennifer’s passion, commitment and deep industry knowledge will help ensure that we increase our impact and continue to transform the lives of people affected by neuromuscular diseases, during this critical time and beyond.”

For more information about MDA, please visit its website at www.mda.org, or click here to access W2O’s “What2Know” podcast interview with O’Connor Vos.

About W2O

Founded by Jim Weiss in 2001, W2O is the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. The firm employs more than 1,300 people in 18 offices across the United States and in Europe, and partners with a growing roster of Fortune 500 organizations, including 23 of the top 25 pharmaceutical companies.

For more information, please visit www.w2ogroup.com.